| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $20,000 | 1 | 8 |
Sells | $10,589,832 | 11 | 92 |
| Verjee Rehan | director | 1 | $20,000 | 0 | $0 | $20,000 |
| KAPLAN GILLA | director | 0 | $0 | 1 | $528,506 | $-528,506 |
| Bensen Daniel | Chief Operating Officer | 0 | $0 | 8 | $4.81M | $-4.81M |
| MORE ROBERT J | director | 0 | $0 | 2 | $5.25M | $-5.25M |
Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is advancing a pipeline of programs addressing other critical conditions, including FGFR2-related intrahepatic cholangiocarcinoma, FGFR3-associated …
Over the last 12 months, insiders at Tyra Biosciences, Inc. have bought $20,000 and sold $10.59M worth of Tyra Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Tyra Biosciences, Inc. have bought $9.65M and sold $8.97M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Verjee Rehan (director) — $20,000.
The last purchase of 972 shares for transaction amount of $20,000 was made by Verjee Rehan (director) on 2026‑09‑09.
| 2026-09-09 | Verjee Rehan | director | 971.89 0.0015% | $20.58 | $20,000 | -3.09% | ||
| 2026-03-25 | Sale | KAPLAN GILLA | director | 14,295 0.0268% | $36.97 | $528,506 | -20.35% | |
| 2026-02-12 | Sale | Bensen Daniel | Chief Discovery Officer | 8,000 0.0169% | $32.87 | $262,965 | +5.89% | |
| 2026-01-12 | Sale | Bensen Daniel | Chief Discovery Officer | 8,000 0.0149% | $28.52 | $228,186 | +7.09% | |
| 2025-12-19 | Sale | MORE ROBERT J | director | 10,000 0.0184% | $25.00 | $250,000 | +19.09% | |
| 2025-12-12 | Sale | Bensen Daniel | Chief Discovery Officer | 8,000 0.015% | $22.64 | $181,159 | +34.11% | |
| 2025-11-21 | Sale | MORE ROBERT J | director | 246,871 0.4436% | $20.25 | $5M | +39.49% | |
| 2025-11-19 | Sale | Bensen Daniel | Chief Operating Officer | 49,956 0.0919% | $16.32 | $815,297 | +77.08% | |
| 2025-11-18 | Sale | Bensen Daniel | Chief Operating Officer | 75,633 0.142% | $16.07 | $1.22M | +83.42% | |
| 2025-11-17 | Sale | Bensen Daniel | Chief Operating Officer | 20,072 0.0383% | $16.18 | $324,798 | +84.97% | |
| 2025-11-14 | Sale | Bensen Daniel | Chief Operating Officer | 110,228 0.2122% | $16.02 | $1.77M | +86.94% | |
| 2025-11-13 | Sale | Bensen Daniel | Chief Operating Officer | 1,111 0.0021% | $16.00 | $17,780 | +88.58% | |
| 2025-06-18 | Sale | KAPLAN GILLA | director | 9,568 0.0185% | $9.78 | $93,596 | +141.79% | |
| 2025-06-17 | Sale | KAPLAN GILLA | director | 10 <0.0001% | $10.35 | $104 | +137.85% | |
| 2025-06-16 | Sale | KAPLAN GILLA | director | 6,814 0.013% | $10.38 | $70,726 | +123.09% | |
| 2025-06-16 | RA CAPITAL MANAGEMENT, L.P. | 11,813 0.022% | $10.13 | $119,666 | +123.09% | |||
| 2025-06-13 | Sale | KAPLAN GILLA | director | 15,000 0.0279% | $10.31 | $154,583 | +116.83% | |
| 2025-06-13 | RA CAPITAL MANAGEMENT, L.P. | 120,167 0.2214% | $10.20 | $1.23M | +116.83% | |||
| 2025-06-12 | Sale | KAPLAN GILLA | director | 30,000 0.0564% | $10.31 | $309,255 | +118.78% | |
| 2025-06-12 | RA CAPITAL MANAGEMENT, L.P. | 31,307 0.0582% | $10.20 | $319,331 | +118.78% |
| MORE ROBERT J | director | 3823425 6.4084% | $81.71M | 1 | 2 | <0.0001% |
| Verjee Rehan | director | 972 0.0016% | $20,769.38 | 1 | 0 | |
| RA CAPITAL MANAGEMENT, L.P. | 10259291 17.1954% | $219.24M | 8 | 0 | +79.87% | |
| Boxer Capital, LLC | 10 percent owner | 6448359 10.808% | $137.8M | 2 | 0 | <0.0001% |
| Alta Partners NextGen Fund II Management, LLC | 10 percent owner | 4080296 6.8389% | $87.2M | 1 | 0 | <0.0001% |
| Cormorant Asset Management, LP | 1069932 1.7933% | $22.86M | 1 | 0 | <0.0001% | |
| Fuhrman Alan | Chief Financial Officer | 12849 0.0215% | $274,583.13 | 1 | 0 | <0.0001% |
$831,902,292 | 108 | 9.34% | $1.2B | |
$15,410,062 | 81 | 39.69% | $975.93M | |
$54,660,406 | 66 | 22.24% | $1.5B | |
$530,111,731 | 35 | 8.69% | $1.51B | |
$4,431,947 | 22 | 36.10% | $1.46B |
| Increased Positions | 72 | +55.81% | 6M | +10.45% |
| Decreased Positions | 53 | -41.09% | 4M | -7.98% |
| New Positions | 30 | New | 3M | New |
| Sold Out Positions | 14 | Sold Out | 783,658 | Sold Out |
| Total Postitions | 148 | +14.73% | 57M | +2.47% |
| Ra Capital Management, L.P. | $326,801.00 | 23.02% | 12.2M | 0 | 0% | 2025-09-30 |
| Alta Partners Management Company, L.P. | $109,311.00 | 7.7% | 4.08M | 0 | 0% | 2025-09-30 |
| Nextech Invest, Ltd. | $108,657.00 | 7.65% | 4.06M | 0 | 0% | 2025-09-30 |
| Bvf Inc/Il | $97,778.00 | 6.89% | 3.65M | -294,400 | -7.46% | 2025-09-30 |
| Canaan Partners Xi Llc | $96,661.00 | 6.81% | 3.61M | 0 | 0% | 2025-09-30 |
| Commodore Capital Lp | $90,416.00 | 6.37% | 3.38M | +275,000 | +8.87% | 2025-09-30 |
| Tcg Crossover Management, Llc | $77,640.00 | 5.47% | 2.9M | 0 | 0% | 2025-09-30 |
| Janus Henderson Group Plc | $77,016.00 | 5.42% | 2.87M | +18,514 | +0.65% | 2025-09-30 |
| Vestal Point Capital, Lp | $64,966.00 | 4.58% | 2.42M | -230,000 | -8.66% | 2025-09-30 |
| Kynam Capital Management, Lp | $62,421.00 | 4.4% | 2.33M | 0 | 0% | 2025-09-30 |